PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension

Inflammation in Pulmonary Arterial Hypertension

(2012) Laura C. Price et al.   CHEST

C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension

(2011) David Montani et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A role for coagulation factor Xa in experimental pulmonary arterial hypertension

(2011) Martina Delbeck et al.   CARDIOVASCULAR RESEARCH

Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension

(2011) Beatrijs Bartelds et al.   CHEST

Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2

(2010) G. De Cunto et al.   EUROPEAN RESPIRATORY JOURNAL

Mast cells promote lung vascular remodelling in pulmonary hypertension

(2010) J. Hoffmann et al.   EUROPEAN RESPIRATORY JOURNAL

Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responsesin vitroandin vivo

(2009) T Kanke et al.   BRITISH JOURNAL OF PHARMACOLOGY

Prevention of Mast Cell Degranulation by Disodium Cromoglycate Attenuates the Development of Hypoxic Pulmonary Hypertension in Rats Exposed to Chronic Hypoxia

(2008) Alena Baňasová et al.   RESPIRATION

PAR-2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse

(2007) Gail M. Tennant et al.   ATHEROSCLEROSIS

Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more

(2007) R Ramachandran et al.   BRITISH JOURNAL OF PHARMACOLOGY